ARPA-H awards up to $160M to scientists developing custom genetic medicines
The Advanced Research Projects Agency for Health has awarded a new tranche of funds for companies and institutions developing personalized genetic medicines, with the recipient list dominated by…
Read the full articleYou might also wanna read
STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs
An ARPA-H program to jump-start custom gene editing treatments was delayed by a change in administrations. Now seven labs will get sizable g
Jackson Laboratory and Broad Institute receive $34.5M ARPA-H award for pediatric epilepsy gene editing platform
Pediatric Epilepsies & Rare CNS Gene Editing Platform (PERC) accelerates the development of precision genetic medicines for severe childhood
jax.org·1d ago
How Taxpayer-Funded Research Led to a $2 Million Gene Therapy: The Zolgensma Story
Taxpayers and charities helped develop Zolgensma. Then it debuted at a record price, ushering in a new class of wildly expensive drugs. Its
propublica.org·4d ago
High-cost gene therapies face financing barriers in US healthcare system
“We do not lack cures. We lack the infrastructure to pay for and deliver them,” writes William Padula.
statnews.com·1mo ago
NIH proposes capping number of grants per scientist to broaden research funding distribution
Agency is bringing back a version of a funding limit that was quickly abandoned nearly a decade ago
science.org·1mo ago
Global agricultural innovation investments hit $16bn in 2025 as AI and genetics reshape farming
Startups are combining AI and genetics to make more food for less money
econ.st·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.